Medical Oncologist
CION Cancer Clinics
The contraceptive pill and ovarian cancer risk in gene carriers | CION Cancer Clinics
The combined contraceptive pill lowers the chance of ovarian cancer, and the protection lasts for years after stopping. Studies in BRCA and Lynch carriers point the same way. The open question is breast risk, which may rise slightly while the pill is taken. This page explains the trade-off, who the pill suits, and why it is a bridge rather than a replacement for surgery. At CION Cancer Clinics, our team helps carriers and their families plan checks, next steps and support after a genetic result.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Does the contraceptive pill lower ovarian cancer risk?
- What can the pill do to each of your cancer risks?
- How do you and your doctor decide about the pill?
- The terms on your prescription, in plain language
- The pill compared with risk-reducing surgery
- What this page cannot tell you
- Four things women tell us, and what is actually true
- Common questions about the pill and ovarian risk
The short answer
Does the contraceptive pill lower ovarian cancer risk?
Yes. Taking the combined contraceptive pill for several years lowers the chance of ovarian cancer, and the effect lasts long after the pill is stopped. Studies in BRCA carriers point the same way. It is still a partial effect, and it does not replace the conversation about risk-reducing surgery.
Why it seems to work
Each month the ovary releases an egg and the surface repairs itself afterwards. The combined pill stops that monthly cycle. Fewer cycles over a lifetime seems to mean fewer chances for a harmful change to take hold. Pregnancy and breastfeeding lower the risk in a similar way.
What about gene carriers
The protection seen in the general population also appears in women with a BRCA1 or BRCA2 fault, and in women with Lynch syndrome, where the pill also seems to lower womb cancer risk. The studies in carriers are smaller and mostly look back at women's past pill use rather than testing it directly.
The catch
The pill may slightly raise breast cancer risk while it is being taken. For carriers who already face a raised breast risk, that trade-off needs a careful, personal conversation.
The pill is a contraceptive first. Any cancer benefit is a reason to discuss it, not a reason to start it on your own.Risk by risk
What can the pill do to each of your cancer risks?
One tablet touches several risks at once. They do not all move in the same direction.
Ovarian risk
Goes down, and the longer the pill is used, the larger the effect seems to be. The benefit continues for many years after stopping.
Lower is not zero. Ovarian cancer is still hard to find early.Womb risk
Also goes down with the combined pill. This matters most for women with Lynch syndrome, whose womb cancer risk is raised.
Breast risk
The open question. In the general population there is a small rise while the pill is taken, which fades after stopping. In BRCA carriers the studies disagree, and the concern is greatest for BRCA1.
What doctors weigh
- Which gene fault you carry
- Your age and how long you would take it
- Whether you have had breast cancer before
Other health risks
The pill raises the chance of blood clots. It is not suitable for women who smoke and are older, who have migraine with aura, or who have high blood pressure that is not controlled.
Not sure whether this applies to you?
Ask an oncologistHow it is usually decided
How do you and your doctor decide about the pill?
-
Start with the gene result and family tree
Your counsellor confirms which gene fault you carry and which cancers it raises. The pill matters most where ovarian risk is high.
-
Weigh your breast risk alongside it
Your doctor sets the fall in ovarian risk against any possible rise in breast risk. For some carriers the balance is clear, and for others it is close.
-
Check that the pill is safe for you
Blood pressure, migraine, smoking, weight and any history of clots are checked. A past breast cancer usually rules out hormonal contraception altogether.
-
Plan around marriage and children
Many women use the pill for years before trying for a family. The pill fits that stage well, and it can be stopped whenever you want to conceive.
-
Keep the surgery conversation open
For BRCA carriers, removing the ovaries and tubes after childbearing is still the most effective step. The pill is often used while that decision waits.
Words you will hear
The terms on your prescription, in plain language
- Combined pill
- A pill with two hormones, an oestrogen and a progestogen. This is the type studied for ovarian protection.
- Progestogen-only pill
- A pill with one hormone. Whether it protects the ovaries in the same way is much less clear.
- Ovulation
- The monthly release of an egg from the ovary. The combined pill switches this off while you take it.
- Risk-reducing surgery
- An operation to remove the ovaries and fallopian tubes before cancer can start there.
- BRCA1 and BRCA2
- The two best-known genes linked to both breast and ovarian cancer. A fault in either raises ovarian risk.
- Lynch syndrome
- An inherited condition that raises bowel, womb and ovarian cancer risk.
Side by side
The pill compared with risk-reducing surgery
The combined pill
Removing ovaries and tubes
Lowers ovarian risk partly
Lowers ovarian risk far more
Can be stopped any time
Cannot be undone
Keeps the chance of pregnancy
Ends natural pregnancy
May slightly raise breast risk
Brings early menopause if done young
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being straight with you
What this page cannot tell you
It cannot tell you whether the pill is a good idea for you. That depends on your gene, your age, your plans for children and your breast risk. What your specific variant means is a question for the counsellor who ordered the test.
It cannot settle the breast question
The research on breast risk in carriers is mixed, and the studies are small. Anyone who tells you the answer is certain in either direction is going beyond the evidence. Your doctor can explain which way the balance leans for your gene.
Who this does not apply to
Most women do not take the pill to prevent cancer. It is not advised for this reason in women at average risk. It is usually avoided after a breast cancer diagnosis, and it adds nothing after both ovaries have been removed.
Not every pill sold in India is the same pill. The weekly non-hormonal pill works differently and has not been shown to protect the ovaries.Commonly believed
Four things women tell us, and what is actually true
"The pill causes cancer, so a carrier should never touch it."
It lowers some cancer risks and may slightly raise another. For many carriers the overall balance favours it for a time. It is a personal decision, not a blanket rule.
"If I take the pill, I do not need to think about surgery."
The pill lowers risk partly. For BRCA carriers, removing the ovaries and tubes after childbearing lowers it far more. The pill is a bridge, not a replacement.
"Taking the pill will make it harder to have children later."
Fertility usually returns soon after stopping. The pill does not use up eggs or damage the ovaries. Age affects fertility far more than past pill use.
"Regular ultrasound scans protect me just as well."
Ovarian scans and blood tests have not been shown to find cancer early enough to save lives. They are no substitute for lowering the risk in the first place.
Questions we are asked
Common questions about the pill and ovarian risk
How long do I need to take it to get the benefit?
The benefit seems to grow with longer use and continues after stopping. Short use gives a smaller effect. Your doctor will balance the length of use against your breast risk, rather than giving a fixed target for everyone.
Is the pill safe for BRCA1 carriers?
It is a closer call than for BRCA2 carriers, because the concern about breast risk is larger in BRCA1. Many doctors still discuss it, especially for younger women waiting for surgery. It needs a personal conversation.
I have Lynch syndrome. Does the pill help me?
It may lower both ovarian and womb cancer risk, which are the two gynaecological cancers raised in Lynch syndrome. It does not affect bowel surveillance, which carries on as planned. Discuss it with your gynaecologist or oncologist.
Can I use the pill if I have had breast cancer?
Usually not. Hormonal contraception is generally avoided after breast cancer. A copper coil or barrier method is the usual choice, and your oncologist will advise on what is safe for you.
Does the free government pill count?
The combined pill supplied through government family planning is the same broad type studied for ovarian protection. The weekly non-hormonal pill is different. Check with your doctor which one you have been given.
What about the hormonal coil or injection?
The evidence for ovarian protection is much less clear for these. The hormonal coil may lower womb cancer risk, which can matter in Lynch syndrome. Ask your doctor to compare the options for your situation.
Should I stop the pill before risk-reducing surgery?
Your surgical team will tell you. Because the pill raises clot risk, some surgeons ask you to stop it for a period before an operation. Never stop or start without checking first.
Who should I talk to about this?
Your genetic counsellor and gynaecologist together. Bring your gene report and a list of your medicines. Call the CION helpline if you are not sure who is managing your risk, and someone will point you to the right clinic.
Your Specialists
Meet CION's oncologists. Bring your family history or genetic report to them.
Our medical oncologists see people with a strong family history of cancer, arrange genetic counselling and testing where it fits, and plan the checks that follow.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Patient stories
Hear it from people we have treated
Every story is a video, in the patient's own words. Nothing here is a written testimonial.
Sources
- National Cancer Institute — Oral Contraceptives (Birth Control Pills) and Cancer Risk
- National Cancer Institute — Genetics of Breast and Gynecologic Cancers (PDQ) - Health Professional Version
- GeneReviews (NCBI) — BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
- National Cancer Institute — Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Prevention (PDQ) - Patient Version
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Ways to reduce hereditary cancer riskEvery option on one page, from scans to surgeryOvarian surveillance: why it works poorlyWhy scans cannot stand in for lowering the riskHRT after risk-reducing ovary removalWhat happens to hormones after the surgerySurgery, medication or surveillance: how to weigh themWhere the pill fits beside the other choices
Talk to us
Unsure whether the pill is right for your gene result?
Tell us which gene fault you carry and what you are weighing up, and we will help you find the right counsellor or gynaecologist to talk it through. You do not have to decide anything on the call. One helpline serves every CION centre.